MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.
Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows:
Time | 8:30 A.M EDT |
Toll free (U.S.) | (866) 374-5140 |
International (U.S) | (404) 400-0571 |
Germany | 8001897777 |
Israel | 4044000571 |
Access Code | 43100176# |
Webcast (live and replay) | https://edge.media-server.com/mmc/p/fz7je7rr under the ‘Investors’ section’. |
The archived webcast will be available via the following link
https://edge.media-server.com/mmc/p/fz7je7rr or through the ‘Investors’ section’ on www.rewalk.com.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.
Investor Contact:
Almog Adar
Director of Finance
ReWalk Robotics Ltd.
T: +972-4-9590130
E: investorrelations@rewalk.com
BOSTON, April 21, 2025 /PRNewswire/ -- Onsite Mammography ("Onsite") announces a data incident that impacted…
New data demonstrates effectiveness of SPLENDOR X™'s dual-wavelength simultaneous laser emission technology for improved hair…
"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…
NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…
Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…
COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP)…